The estimated Net Worth of Fred T Hadeed is at least $1.78 Million dollars as of 17 August 2006. Fred Hadeed owns over 3,819 units of United Therapeutics Corp stock worth over $1,668,290 and over the last 20 years Fred sold UTHR stock worth over $113,704.
Sign up
Fred Hadeed UTHR stock SEC Form 4 insiders trading
Fred has made over 41 trades of the United Therapeutics Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently Fred exercised 3,819 units of UTHR stock worth $87,646 on 17 August 2006.
The largest trade Fred's ever made was exercising 3,819 units of United Therapeutics Corp stock on 17 August 2006 worth over $87,646. On average, Fred trades about 2,996 units every 14 days since 2004. As of 17 August 2006 Fred still owns at least 4,819 units of United Therapeutics Corp stock.
You can see the complete history of Fred Hadeed stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Fred Hadeed's mailing address?
Fred's mailing address filed with the SEC is , , , , .
Insiders trading at United Therapeutics Corp
Over the last 20 years, insiders at United Therapeutics Corp have traded over $68,910,395 worth of United Therapeutics Corp stock and bought 229,703 units worth $13,655,671 . The most active insiders traders include Martine A Rothblatt, David Zaccardelli, and Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of $2,310,818. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth $991,341.
What does United Therapeutics Corp do?
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
What does United Therapeutics Corp's logo look like?
Complete history of Fred Hadeed stock trades at United Therapeutics Corp
United Therapeutics Corp executives and stock owners
United Therapeutics Corp executives and other stock owners filed with the SEC include:
-
Martine Rothblatt,
Chairman of the Board, Chief Executive Officer -
Michael Benkowitz,
President, Chief Operating Officer -
Paul Mahon,
Executive Vice President, General Counsel, Corporate Secretary -
James Edgemond,
Chief Financial Officer, Treasurer -
Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.,
Founder, Chairman & CEO -
Dr. Martine A. Rothblatt,
Founder, Chairman & CEO -
Michael I. Benkowitz,
Pres & COO -
Paul A. Mahon,
Exec. VP, Gen. Counsel & Corp. Sec. -
Paul A. Mahon J.D.,
Exec. VP, Gen. Counsel & Corp. Sec. -
James C. Edgemond,
CFO & Treasurer -
Christopher Patusky,
Lead Independent Vice Chairman of the Board -
Christopher Causey,
Independent Director -
Richard Giltner,
Independent Director -
Louis Sullivan,
Independent Director -
Tommy Thompson,
Independent Director -
Nilda Mesa,
Independent Director -
Judy Olian,
Independent Director -
Katherine Klein,
Independent Director -
Raymond Kurzweil,
Independent Director -
Raymond Dwek,
Independent Director -
Linda Maxwell,
Director -
Dewey Steadman C.F.A.,
Head of Investor Relations -
Leigh Peterson,
VP of Product Devel. -
Gil Golden,
Sr. VP & Chief Medical Officer -
Patrick Poisson,
Exec. VP of Technical Operations -
Kevin T. Gray,
Sr. VP of Strategic Operations & Logistics -
Holly Hobson,
Associate VP of HR -
Dewey Steadman C.F.A., CFA,
Head of Investor Relations -
Jan Malcolm,
-
Ray Kurzweil,
-
Roger Jeffs,
President & COO -
Fred T Hadeed,
EVP & CFO -
David Zaccardelli,
EVP & Chief Operating Officer -
John Maxim Ferrari,
CFO & Treasurer -
R Paul Gray,
Director -
Lilly & Co Eli,
Director, Chairman and CEO